#LungCancer - ⭐ #6: Efficacy and Safety of Anti-PD-1 Plus Anlotinib in Patients With Advanced #NSCLC After Previous Systemic Treatment Failure—A Retrospective Study 👨⚕️👩⚕️ Peiliang Wang, Xiaozhuang Fang et al. Read here 👉 https://t.co/tyydRVttGb #LCsm
6,544 followers
6,544 followers
New research: Efficacy and Safety of Anti-PD-1 Plus Anlotinib in Patients With Advanced Non–Small-Cell Lung Cancer After Previous Systemic Treatment Failure—A Retrospective Study: Background Pre-clinical and clinical evidences support that… https://t.co/Bm
792 followers
Efficacy and Safety of Anti-PD-1 Plus Anlotinib in Patients With Advanced Non–Small-Cell Lung Cancer After Previous Systemic Treatment Failure—A Retrospective Study https://t.co/wIxJLk4mLr